Reversal of Supraventricular Tachycardia with Aberration afte Initiation of Pseudoanalgesia with Propofol: Case Report

Main Article Content

Estanislao Antonio Calixto
Marcos García Aranda
Kenia Hernandez Mejia
Johan Alexander Mendoza Alva
Jose Osvaldo Medina Ruiz

Abstract




Supraventricular tachycardia (SVT) is a heterogeneous group of arrhythmias used to describe tachycardias involving cardiac tissue at or above the level of the bundle of His. They usually appear in subjects without structural heart disease. However, they can sometimes cause palpitations, dyspnea, sweating, angina, or vague chest discomfort, particularly in patients with underlying heart disease. We present the case of a patient with SVT reverted during pseudonalgesia with propofol. This is a 48-year-old male patient who came for presenting a sensation of intense palpitations, an electrocardiogram was taken where the presence of wide QRS tachycardia was observed. It was decided to administer procedural sedation for synchronized electrical cardioversion, however, he presented cardioversion upon administration of propofol 50 mg (Fig 1B) after 5 minutes, improving the symptoms. Studies of propofol have described its influence on the cardiac conduction system and the ability to modify the phases of the action potential by acting on the ion channels of the myocyte membrane. Therefore, it would be interesting to see case series from large centers and electrophysiology studies that show the possible antiarrhythmic role of drugs such as propofol not described in the literature.




Article Details

How to Cite
Antonio Calixto, E., García Aranda, M. ., Kenia Hernandez Mejia, Mendoza Alva, J. A. ., & Medina Ruiz , J. O. . (2023). Reversal of Supraventricular Tachycardia with Aberration afte Initiation of Pseudoanalgesia with Propofol: Case Report. International Journal of Medical Science and Clinical Research Studies, 3(10), 2407–2409. https://doi.org/10.47191/ijmscrs/v3-i10-55
Section
Articles

References

I. Kotadia ID, Williams SE, O'Neill M. Supraventricular tachycardia: An overview of diagnosis and management, Clinical Medicine 2020 Vol 20, No 1: 43

II. Buttà C, Tuttolomondon A, Raimondo DD, Milio G, Miceli S, et al. The supraventricular tachycardias: Proposal of a diagnostic algorithm for the narrow complex tachycardias. Journal of Cardiology 61 (2013) 247–255

III. Almendral J, Castellanos E, Ortiz M. Paroxysmal Supraventricular Tachycardias and Preexcitation Syndromes. Vol. 65. Issue 5. Pages 456-469

IV. Medrano A, Moyab R, Escot I. Paroxysmal supraventricular tachycardia (presentation of two cases). SEMERGEN 2001; 27:594-596

V. Brugada J, Katritsis DG, Arbelo E, Arribas F, Bax JJ, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. European Heart Journal (2020) 41, 655720

VI. Tinnirello JM, Magaldi M, Fontanals J, Masgoret P, Bravo JC. Sinus reversal of supraventricular tachyarrhythmias after propofol administration. A case series.

VII. Lorentz MN, Vianna BSB. Arritmias Cardíacas y Anestesia. Rev Bras Anestesiol 2011; 61: 6: 440-448

Most read articles by the same author(s)

1 2 > >>